Skip to content

Clinical trials

Completed Heart Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Diseases Status: Completed Country / region: China Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20081
20091
20102
20122
20133
20141
20174
20181
20201
20223
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
China National Center for Cardiovascular Diseases2
GlaxoSmithKline2
Medtronic Cardiac Rhythm and Heart Failure2
AstraZeneca1
Bayer1
Changchun University of Chinese Medicine1
Children's Hospital Medical Center, Cincinnati1
Fu Wai Hospital, Beijing, China1
Hangzhou NOYA MedTech Co. Ltm.1
Harbin Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Diseases24
Cardiovascular Diseases12
Coronary Artery Disease9
Coronary Disease8
Arteriosclerosis7
Myocardial Ischemia6
Vascular Diseases5
Arterial Occlusive Diseases4
Acute Coronary Syndrome3
Angina Pectoris3

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.